Postural Re-education for Adolescent Scoliosis

(RCT-RPG Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen by Carole Fortin, PhD

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: St. Justine's Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to see if GPR, a type of physical therapy focusing on posture and muscle exercises, can help adolescents with scoliosis. The goal is to improve their spine alignment, reduce pain, and enhance their overall physical health.

Research Team

Carole Fortin, PhD

Principal Investigator

CHU Sainte-Justine/Université de Montréal

Eligibility Criteria

This trial is for adolescents aged 10-16 with mild to moderate scoliosis (Cobb angle between 15º and 45º) who are still growing (Risser sign ≤3) and can travel weekly for treatment. It's not for those planning surgery, already wearing a brace for three months, or with conditions other than Adolescent Idiopathic Scoliosis.

Inclusion Criteria

having recent x-rays (4-6 weeks)

with a risk of progression index > 1.3

I can travel weekly for the treatment.

Exclusion Criteria

worn a brace for at least three months prior to GPR intervention

I am scheduled for surgery.

I have undergone surgery.

Treatment Details

Interventions

• Global postural re-education (Behavioural Intervention)

Trial Overview The study tests if Global Postural Re-education (GPR), involving special exercises and posture training, can help manage scoliosis better than standard care alone. Participants will be randomly assigned to receive either GPR plus standard care or just standard care over a period of up to one year.

Participant Groups

Group I: GPR group Experimental Treatment 1 Intervention

GPR interventions added to standard care (observation or brace)

Group II: Standard care group Active Control 1 Intervention

Observation or brace plus conventional physiotherapy exercises on video

Who Is Running the Clinical Trial?

St. Justine's Hospital

Lead Sponsor

Trials

205

Recruited

87,300+

Dr. Marc Girard

St. Justine's Hospital

Chief Medical Officer since 2018

MD from Université de Montréal

Dr. Fabrice Brunet

St. Justine's Hospital

Chief Executive Officer since 2009

Medical studies at Faculty of Medicine Cochin Port Royal, University of Paris V; Management studies at Paris Business School, Harvard Public Health School of Management, and University of Toronto

CHU de Québec

Collaborator

Trials

2

Recruited

140+

Laval University

Collaborator

Trials

439

Recruited

178,000+

Dr. Pedro O de Campos-Lima

Laval University

Chief Medical Officer since 1998

MD from Federal University of Juiz de Fora, PhD in Tumor Biology from Karolinska Institute

Dr. Manuel Caruso

Laval University

Chief Executive Officer since 1998

PhD in Virology from Pierre and Marie Curie University

Shriners Hospitals for Children

Collaborator

Trials

98

Recruited

23,900+

Phillip Grady

Shriners Hospitals for Children

Chief Executive Officer since 2021

DHA, FACHE

Dr. Frances A. Farley

Shriners Hospitals for Children

Chief Medical Officer since 2021

MD from Weill Cornell University Medical College

Université de Montréal

Collaborator

Trials

223

Recruited

104,000+

Houda Bahig

Université de Montréal

Chief Medical Officer since 2021

MD from Université de Montréal

Daniel Jutras

Université de Montréal

Chief Executive Officer since 2020

LLB from Université de Montréal, LLM from Harvard University